These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 8510941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
    Yam JW, Zheng JY, Hsiao WL.
    Biochem Biophys Res Commun; 1999 Dec 20; 266(2):472-80. PubMed ID: 10600527
    [Abstract] [Full Text] [Related]

  • 5. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M, Grimaldi M, Ruaro E, Pavlenko M, Schneider C, Jenkins JR.
    Oncogene; 1996 Aug 01; 13(3):589-98. PubMed ID: 8760300
    [Abstract] [Full Text] [Related]

  • 6. Specific and complex interactions of murine p53 with DNA.
    Weissker SN, Müller BF, Homfeld A, Deppert W.
    Oncogene; 1992 Oct 01; 7(10):1921-32. PubMed ID: 1408133
    [Abstract] [Full Text] [Related]

  • 7. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N, Ossovskaya V, Vasiliev J, Chumakov P, Kopnin B.
    Oncogene; 1997 Dec 11; 15(24):2985-9. PubMed ID: 9416842
    [Abstract] [Full Text] [Related]

  • 8. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 11; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 9. Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells.
    Wyllie FS, Haughton MF, Blaydes JP, Schlumberger M, Wynford-Thomas D.
    Oncogene; 1995 Jan 05; 10(1):49-59. PubMed ID: 7529918
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
    Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, May P.
    Oncogene; 1989 Dec 05; 4(12):1483-8. PubMed ID: 2531855
    [Abstract] [Full Text] [Related]

  • 15. Phosphorylation of p53 in primary, immortalised and transformed Balb/c mouse cells.
    Patschinsky T, Deppert W.
    Oncogene; 1990 Jul 05; 5(7):1071-6. PubMed ID: 2142761
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the anti-p53 antibody response in cancer patients.
    Labrecque S, Naor N, Thomson D, Matlashewski G.
    Cancer Res; 1993 Aug 01; 53(15):3468-71. PubMed ID: 8339249
    [Abstract] [Full Text] [Related]

  • 17. Association of JNK1 with p21waf1 and p53: modulation of JNK1 activity.
    Xue Y, Ramaswamy NT, Hong X, Pelling JC.
    Mol Carcinog; 2003 Jan 01; 36(1):38-44. PubMed ID: 12503078
    [Abstract] [Full Text] [Related]

  • 18. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J, Schmid G.
    Cell Mol Biol Lett; 2001 Jan 01; 6(2):117-40. PubMed ID: 11544635
    [Abstract] [Full Text] [Related]

  • 19. 'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain.
    Lányi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA, Deb S.
    Oncogene; 1998 Jun 18; 16(24):3169-76. PubMed ID: 9671396
    [Abstract] [Full Text] [Related]

  • 20. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P, Bazar K, Huper G, Lozano G, Marks J, Iglehart JD.
    Oncogene; 1996 Sep 19; 13(6):1315-22. PubMed ID: 8808706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.